Patients who treat severe allergic reactions with EpiPens have been told to use the devices beyond their labelled expiry dates amid an international supply shortage.
Manufacturers have been handed approval by the UK’s medicines regulator to extend the shelf life of certain batches of EpiPen by four months.
EpiPens are the most common type of adrenaline auto-injector used in Britain by people with potentially lethal allergies to foods, insect bites and medications.
Mylan, which markets and distributes the product in the UK, said shortages were due to supply problems experienced by the drug’s manufacturer, pharmaceutical giant Pfizer.
Mylan UK – We believe the extension of use beyond the labelled expiry date will temporarily address patients’ access to and use of EpiPen auto-injectors.